The future of healthcare and machine intelligence, featuring Dr Phillip Alvelda, the founder and chairman of Medio Labs.  The pandemic accelerated the introduction of direct-to-consumer healthcare with clinical grade accuracy. Phillip explains how AI will amplify this process by reducing cost to scale. But the prospect of constant surveillance raises other concerns, and that leads to a lively Futurists debate about China’s advances in AI and a new round of US export controls.